StudyFinder
Phase II - Long-term Safety and Efficacy in Adults With CDIP (ADHERE+)
OPEN TO ACCRUAL
drug: Argx-113
Diseases of Nervous System and Sense Organs (320-389)
Smith, LaVon - lavon.smith@vcuhealth.org
Gwathmey, Kelly
II
HM20018942
NCT04280718
See this study on ClinicalTrials.gov